- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 1 Diabetes Mellitus With Hypoglycaemia in New Zealand
Total 1385 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Germany, Spain, Taiwan, Hungary, Poland, Korea, Republic of, Austria, New Zealand, United Kingdom, Czechia, Puerto Rico
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Italy, United Kingdom, France, Serbia, Germany, South Africa, Canada, Ukraine, United Arab Emirates
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Turkey, Canada, Finland, France, Hungary, Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Poland, Russian Federation, Slovakia, United Kingdom, Argentina, Norway, Turkey, Israel, Czechia, South Africa, Hungary, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Puerto Rico
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
Mannkind CorporationCompletedType 2 DiabetesUnited States, Russian Federation, Brazil, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, Russian Federation, Spain, United States, Canada, Puerto Rico, Hungary, Peru, Romania, Poland, Germany, Czech Republic, India, Colombia, Denmark, Finland
-
Janssen Research & Development, LLCCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
AstraZenecaCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
-
LifeScanSynexus(UK); CPS(UK); Battelle CRO(US); RPS CRO(US); Robertson Centre For Biostatistics...CompletedDiabetes Mellitus, Type 2United States, United Kingdom, Canada
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, United Kingdom, Germany, Mexico, Romania, Argentina, Canada, Puerto Rico, Israel, Italy, Slovakia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyFrance, Poland, United States, Belgium, Germany, Spain, India, Romania, South Africa, Canada, Australia, Korea, Republic of, New Zealand, Russian Federation, Brazil, Malaysia, Latvia, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Italy, Mexico, Russian Federation, United Kingdom, Spain, Malaysia, Croatia, Greece, Korea, Republic of, Japan, South Africa, Algeria, Thailand, Argentina, Brazil, Canada, Romania
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2India, Turkey, United States, Puerto Rico, Taiwan, Korea, Republic of, Russian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2United States, France, Canada, Brazil, Russian Federation, Germany, Italy, Turkey, India, Mexico, Egypt, United Kingdom, Korea, Republic of, Chile, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, India, Malaysia, Turkey, Argentina, Greece, Australia, Portugal, Thailand, Brazil
-
Eli Lilly and CompanyCompletedDiabetes | Type 2 DiabetesUnited States, China, Germany, Mexico, Brazil, Canada, Japan, Korea, Republic of, Puerto Rico, Czechia, Greece
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States
-
TakedaCompletedDiabetes MellitusUnited States
-
German Diabetes CenterCompletedType 2 Diabetes | Fatty Liver, NonalcoholicGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Japan, Slovakia, Germany, Latvia, South Africa, Czechia, United Arab Emirates, Hungary, Ukraine, Puerto Rico
-
AstraZenecaCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Spain, Russian Federation, Turkey, Austria, India, Korea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, France, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Spain, United Kingdom, Vietnam, Germany, Philippines, Malaysia, Sweden, Estonia, Latvia, Lithuania, Finland, Norway and more
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2United States
-
TakedaCompletedType 2 DiabetesUnited States, Poland, United Kingdom, Germany, South Africa, Finland, Estonia, Slovakia, Czech Republic
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation
-
GlaxoSmithKlineCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Sweden, Finland, France, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Russian Federation, Puerto Rico, United Arab Emirates, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Japan, Russian Federation, United Kingdom, France, Mexico, South Africa, Turkey, Argentina, Germany, Romania, Brazil, Ukraine
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
-
Repros Therapeutics Inc.CompletedType 2 Diabetes Mellitus | Secondary HypogonadismUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Japan, Puerto Rico, Canada, France, Mexico, Poland, Russian Federation, Greece
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Ukraine, Argentina, Bulgaria, Hungary, Slovakia, Guatemala, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, India, Taiwan, Poland, Australia, Estonia, Hungary, Germany, Slovakia, Canada, Croatia, Bulgaria, Puerto Rico, Czechia, Slovenia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Italy, Russian Federation, Spain, Canada, Serbia, Slovakia, Germany, Greece, Korea, Republic of, Czechia, Puerto Rico, Bulgaria, Romania, Argentina, Ukraine